Skip to main content
. 2018 Oct 22;8:15572. doi: 10.1038/s41598-018-33629-y

Figure 5.

Figure 5

Hypomethylation of the EN1 Promoter and Increased EN1 Expression in Basal-like Breast Tumors. (A) Arrows indicate seven CpG sites of the EN1 promoter analyzed. (B) Analysis of TCGA HumanMethylation450 Array data showed significantly lower methylation in seven CpG sites of the EN1 promoter in BLBC tumors compared to normal breast tissues and other subtype breast tumors (p < 0.001). Beta values (0 to 1) are relative values increasing from hypomethylation to hypermethylation. (C, D) EN1 expression is significantly higher in basal like tumors compared to other subtype tumors, both in TCGA (C) and our RNA-seq datasets (D). (E) EN1 expression was analyzed using Pan-Cancer RNA-seq datasets and presented as log2 (FPKM + 1) values. Abbreviations of tumor types are described in Fig. 2A legend.